Literature DB >> 7479687

Second-generation octarellins: two new de novo (beta/alpha)8 polypeptides designed for investigating the influence of beta-residue packing on the alpha/beta-barrel structure stability.

A Houbrechts1, B Moreau, R Abagyan, V Mainfroid, G Préaux, A Lamproye, A Poncin, E Goormaghtigh, J M Ruysschaert, J A Martial.   

Abstract

The sequence of octarellin I, the first de novo (beta/alpha)8 polypeptide, was revised according to several criteria, among others the symmetry of the sequence, beta-residue volume and hydrophobicity, and charge distribution. These considerations and the overall conclusions drawn from the first design led to two new sequences, corresponding to octarellins II and III. Octarellin II retains perfect 8-fold symmetry. Octarellin III has the same sequence as octarellin II, except for the beta-strands which exhibit a 4-fold symmetry. The two proteins were produced in Escherichia coli. Infrared and CD spectral analyses of octarellins II and III reveal a high secondary structure content. Non-denaturing gel electrophoresis, molecular sieve chromatography and analytical ultracentrifugation suggest that both of these second-generation artificial polypeptides exist as a mixture of a monomer and a dimer form. Octarellins II and III are at least 10 times more soluble than octarellin I. Urea-induced unfolding followed by fluorescence emission suggests that the tryptophan residues, designed to be buried in the (beta/alpha)8, are indeed packed in the hydrophobic core of both proteins. However, octarellin III displays a higher stability towards urea denaturation, indicating that introducing 4-fold symmetry into the beta-barrel might be important for stability of the overall folding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479687     DOI: 10.1093/protein/8.3.249

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  10 in total

1.  Reverse engineering the (beta/alpha )8 barrel fold.

Authors:  J A Silverman; R Balakrishnan; P B Harbury
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  De novo protein design, a retrospective.

Authors:  Ivan V Korendovych; William F DeGrado
Journal:  Q Rev Biophys       Date:  2020-02-11       Impact factor: 5.318

3.  Sequence replacements in the central beta-turn of plastocyanin.

Authors:  J A Ybe; M H Hecht
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

Review 4.  Evolution, folding, and design of TIM barrels and related proteins.

Authors:  Sergio Romero-Romero; Sina Kordes; Florian Michel; Birte Höcker
Journal:  Curr Opin Struct Biol       Date:  2021-01-13       Impact factor: 6.809

5.  Insights into the fold organization of TIM barrel from interaction energy based structure networks.

Authors:  M S Vijayabaskar; Saraswathi Vishveshwara
Journal:  PLoS Comput Biol       Date:  2012-05-17       Impact factor: 4.475

Review 6.  An overview of enzymatic reagents for the removal of affinity tags.

Authors:  David S Waugh
Journal:  Protein Expr Purif       Date:  2011-08-19       Impact factor: 1.650

Review 7.  Why reinvent the wheel? Building new proteins based on ready-made parts.

Authors:  Olga Khersonsky; Sarel J Fleishman
Journal:  Protein Sci       Date:  2016-02-22       Impact factor: 6.725

8.  Design of symmetric TIM barrel proteins from first principles.

Authors:  Deepesh Nagarajan; Geeta Deka; Megha Rao
Journal:  BMC Biochem       Date:  2015-08-12       Impact factor: 4.059

9.  Octarellin VI: using rosetta to design a putative artificial (β/α)8 protein.

Authors:  Maximiliano Figueroa; Nicolas Oliveira; Annabelle Lejeune; Kristian W Kaufmann; Brent M Dorr; André Matagne; Joseph A Martial; Jens Meiler; Cécile Van de Weerdt
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  De novo design of a four-fold symmetric TIM-barrel protein with atomic-level accuracy.

Authors:  Po-Ssu Huang; Kaspar Feldmeier; Fabio Parmeggiani; D Alejandro Fernandez Velasco; Birte Höcker; David Baker
Journal:  Nat Chem Biol       Date:  2015-11-23       Impact factor: 15.040

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.